School of Medicine
Showing 1-6 of 6 Results
-
Ebrahim Mostafavi
Postdoctoral Scholar, Cardiovascular Institute
BioDr. Ebrahim Mostafavi has so far received training at Stanford Cardiovascular Institute, Stanford University School of Medicine (PostDoc), Northeastern University (Ph.D.), Harvard Medical School (Researcher), and University of Tehran (M.Sc. and B.Sc.). His research interests revolve around the rational engineering and development of nano-biomaterials, nanocarriers, and 3D in vitro models (such as 3D/4D bioprinted constructs, hydrogels, nanofibrous scaffolds, organoids, and vascular grafts) to create biologically complex systems for a range of applications from tissue engineering and regenerative medicine, cancer therapy (especially women’s cancer), biosensing, to infectious diseases, while constantly attempting to find potentials for clinical translations.
Dr. Mostafavi serves as Associate Editor-in-Chief of several prestigious and high-impact journals within Elsevier, Springer, Dove Medical Press, T&F, Frontiers, etc. He is also an Editorial Board Member of 25+ prestigious biomedical, biotechnological, and materials science journals. His scholarly work comprises >150 publications with an H-index of 30 (i10-index= 76) including papers published in The Lancet family (i.e., The Lancet, The Lancet Oncology, The Lancet Infectious Diseases, etc.) and JAMA Network journals (Cardiology, Oncology), and New England Journal of Medicine. So far, he has contributed to writing more than 45 introductory book chapters and edited several books such as “Pharmaceutical Nanobiotechnology for Targeted Therapy” and “Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance”.
